Protein kinase Cα regulates human monocyte O2•- production and low density lipoprotein lipid oxidation

被引:62
作者
Li, Q
Subbulakshmi, V
Fields, AP
Murray, NR
Cathcart, MK
机构
[1] Cleveland Clin Fdn, Dept Cell Biol, Lerner Res Inst, Cleveland, OH 44195 USA
[2] Univ Texas, Med Branch, Sealy Ctr Oncol & Hematol, Galveston, TX 77555 USA
关键词
D O I
10.1074/jbc.274.6.3764
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Our previous studies have shown that human native low density lipoprotein (LDL) can be oxidized by activated human monocytes, In this process, both activation of protein kinase C (PKC) and induction of superoxide anion (O-2(radical anion)) production are required. PKC is a family of isoenzymes, and the functional roles of individual PKC isoenzymes are believed to differ based on subcellular location and distinct responses to regulatory signals. We have shown that the PKC isoenzyme that is required for both monocyte O-2(radical anion) production and oxidation of LDL is a member of the conventional PKC group of PKC isoenzymes (Li, Q., and Cathcart, M.K. (1994) J. Biol. Chem, 269, 17508-17515), The conventional PKC group includes PKC alpha, PKC beta I, PKC beta II, and PKC gamma. With the exception of PKC gamma, each of these isoenzymes was detected in human monocytes, in these studies, we investigated the requirement for select PKC isoenzymes in the process of monocyte-mediated LDL lipid oxidation, Our data indicate that PKC activity was rapidly induced upon monocyte activation with the majority of the activity residing in the membrane/particulate fraction. This enhanced PRC activity was sustained for up to 24 h after activation. PKC alpha, PKC beta I, and PKC beta II protein levels were induced upon monocyte activation, and PKC alpha and PKC beta II substantially shifted their location from the cytosol to the particulate/ membrane fraction. To distinguish between these isoenzymes for regulating monocyte O-2(radical anion) production and LDL oxidation, PKC alpha or PKC beta isoenzyme-specific antisense oligonucleotides were used to selectively suppress isoenzyme expression. We found that suppression of PKC alpha expression inhibited both monocyte-mediated O-2(radical anion) production and LDL lipid oxidation by activated human monocytes, In contrast, inhibition of PKC beta expression (including both PKC beta I and PKC beta II) did not affect O-2(radical anion) production or LDL lipid oxidation, Further studies demonstrated that the respiratory burst oxidase responsible for O-2(radical anion) production remained functionally intact in monocytes with depressed levels of PKC alpha because O-2(radical anion) production could be restored by treating the monocytes with arachidonic acid. Taken together, our data reveal that PKC alpha, and not PKC beta I or PKC beta II, is the predominant isoenzyme required for O-2(radical anion) production and maximal oxidation of LDL by activated human monocytes.
引用
收藏
页码:3764 / 3771
页数:8
相关论文
共 47 条
[31]  
MAJUMDAR S, 1991, J BIOL CHEM, V266, P9285
[32]   ACTIVATION OF THE RESPIRATORY BURST ENZYME FROM HUMAN-NEUTROPHILS IN A CELL-FREE SYSTEM - EVIDENCE FOR A SOLUBLE COFACTOR [J].
MCPHAIL, LC ;
SHIRLEY, PS ;
CLAYTON, CC ;
SNYDERMAN, R .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 75 (05) :1735-1739
[33]   LOCALIZATION OF PROTEIN-KINASES BY ANCHORING PROTEINS - A THEME IN SIGNAL-TRANSDUCTION [J].
MOCHLYROSEN, D .
SCIENCE, 1995, 268 (5208) :247-251
[34]  
MYERS MA, 1985, J IMMUNOL, V135, P3411
[35]  
Park JW, 1998, EXP HEMATOL, V26, P37
[36]  
Park JW, 1997, J BIOL CHEM, V272, P11035
[37]   RAPID MICROASSAYS FOR THE MEASUREMENT OF SUPEROXIDE AND HYDROGEN-PEROXIDE PRODUCTION BY MACROPHAGES IN CULTURE USING AN AUTOMATIC ENZYME-IMMUNOASSAY READER [J].
PICK, E ;
MIZEL, D .
JOURNAL OF IMMUNOLOGICAL METHODS, 1981, 46 (02) :211-226
[38]  
PONTREMOLI S, 1990, J BIOL CHEM, V265, P706
[39]  
PRABHAKAR U, 1993, EUR CYTOKINE NETW, V4, P31
[40]   Induction of 15-lipoxygenase expression by IL-13 requires tyrosine phosphorylation of Jak2 and Tyk2 in human monocytes [J].
Roy, B ;
Cathcart, MK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (48) :32023-32029